Previous 10 | Next 10 |
2023-09-15 18:11:16 ET A notable price target cut from an analyst was followed by a dip in the price of DexCom (NASDAQ: DXCM) stock on Friday. Investors traded out of the specialty medical device maker, reducing its value by more than 5%. That was a far steeper decline than the 1.2%...
2023-09-14 16:28:35 ET More on DexCom, Tandem Diabetes, Insulet Why DexCom May Be Up To 40% Undervalued Tandem Diabetes: Cash Flow And Profitability Trends A Drag On Equity Performance, Reiterate Hold Insulet: Losing More Weight Dexcom Denies Weight Loss Drug...
2023-09-12 08:00:00 ET Summary DexCom is a leading healthcare stock that has seen significant growth, with shares returning close to 1,400% in the past decade. DXCM stock has faced resistance and is currently 37% below its all-time high, partly due to competition from weight loss ...
DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring for people with diabetes, today announced the availability of its Dexcom ONE real-time CGM sensor via reimbursement, in France. Dexcom’s announcement brings the company’s highly researched ...
2023-09-07 13:38:45 ET More on Medtronic, Insulet, etc. Compare metrics for MDT to PODD, TNDM Medtronic plc ( MDT ) Wells Fargo 2023 Healthcare Conference (Transcript) Medtronic: The Crossroads Of Its Growth Trajectory Tandem Diabetes: Cash Flow And Profi...
2023-09-07 11:41:22 ET Summary DexCom is a major player in the continuous glucose monitoring space, with steadily growing revenues and a breakout year in 2020. DXCM's market cap valuation has reached $40 billion, leading to high expectations for future growth. Dexcom faces new...
2023-09-06 13:47:07 ET More on Abbott, DexCom, etc. Compare metrics for ABT to DXCM, MDT, SENS Medtronic: The Crossroads Of Its Growth Trajectory Medtronic: The Tide Is Turning Medtronic: Dark Clouds Are Clearing - Outperformance Ahead Senseonics Face...
2023-09-01 07:50:37 ET More on DexCom DexCom: I Expect Growth To Continue At This Strong Rate, Buy DexCom: Fantastic Growth But A High Premium To Pay Right Now DexCom boosts 2023 revenue guidance on Q2 results Dividend for DexCom For further details s...
The world’s most connected continuous glucose monitoring system, † Dexcom G6, is now the first and only CGM to connect with the Omnipod 5 Automated Insulin Delivery (AID) System in Germany. DexCom, Inc. (Nasdaq: DXCM), global manufacturer of systems for real-time c...
2023-08-29 13:29:41 ET More on IHI IHI: Too Expensive Considering Long-Term Rate Uncertainty Johnson & Johnson’s MedTech performance rallies industry Life science tools industry drags healthcare in S&P 500 MedTech, hospital stocks slump after T...
News, Short Squeeze, Breakout and More Instantly...
2024-07-04 10:00:00 ET Growth-oriented investors have experienced a bit of a roller-coaster ride over the past few years. Many companies in the "growth stock" category were struggling just two years ago, but in the bull market we are now experiencing, they're delivering very different resul...
DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2024 financial results after market close on Thursday, July 25, 2024. Management will hold a conference call to review the company's second quarter 2024 performance starting at 4:30 p.m. (Eastern Time) on the...